title: American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
authors.affiliation: Division of Gastroenterology, University of California, San Francisco School of Medicine, San Francisco, California.
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Terdiman
authors.forename: Claudia B
authors.initials: CB
authors.lastname: Gruss
authors.forename: Joel J
authors.initials: JJ
authors.lastname: Heidelbaugh
authors.forename: Shahnaz
authors.initials: S
authors.lastname: Sultan
authors.forename: Yngve T
authors.initials: YT
authors.lastname: Falck-Ytter
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005762:Gastroenterology; D006801:Humans; D015122:Mercaptopurine / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D012074:Remission Induction; D012955:Societies, Medical; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014481:United States
chemical_list: D014409:Tumor Necrosis Factor-alpha; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate
keywords: AGA; American Gastroenterological Association Institute; CD; Crohn's disease; Development and Evaluation; GRADE; Grading of Recommendations Assessment; PICO; TNF; and outcome; comparator; intervention; population; tumor necrosis factor